Insights

Growing Gene Therapy Market PROGEN specializes in advanced AAV analytical tools, viral titers, and high-quality antibodies tailored for gene therapy applications, positioning it well to capitalize on the expanding market for gene therapies and personalized medicine.

Recent Product Launch The launch of new Simple Plex AAV viral titer assays demonstrates ongoing innovation and product development, presenting opportunities to upsell or cross-sell these advanced testing solutions to current and prospective customers.

Strategic Collaborations Partnerships with bio-tech giants like Bio-Techne and Thermo Fisher Scientific highlight potential avenues for joint marketing, bundled offerings, and broader distribution channels to reach key research and biotech clients.

Acquisition & Expansion The acquisition of EuroProxima's antibody lines and the recent acquisition by Yuhan USA indicate growth opportunities through expanded product portfolios and access to new customer bases in the antibody and biotech sectors.

Targeted Customer Segments With a focus on academia, biotech, and pharmaceutical industries, PROGEN's niche offerings are well-positioned to serve high-growth R&D segments seeking reliable, high-quality reagents and tools for gene therapy development, enabling targeted sales strategies.

PROGEN Tech Stack

PROGEN uses 8 technology products and services including Hotjar, Open Graph, Amazon Simple Email Service, and more. Explore PROGEN's tech stack below.

  • Hotjar
    Analytics
  • Open Graph
    Content Management System
  • Amazon Simple Email Service
    Email
  • Prototype
    Javascript Frameworks
  • reCAPTCHA
    Security
  • Google Tag Manager
    Tag Management
  • FedEx
    Transportation And Fleet Management
  • CivicTheme
    UI Frameworks

Media & News

PROGEN's Email Address Formats

PROGEN uses at least 2 format(s):
PROGEN Email FormatsExamplePercentage
First.Last@progen.deJohn.Doe@progen.de
100%
First.Last@progen.comJohn.Doe@progen.com
100%

Frequently Asked Questions

Where is PROGEN's headquarters located?

Minus sign iconPlus sign icon
PROGEN's main headquarters is located at Maaßstraße 30, Heidelberg, DE. The company has employees across 6 continents, including EuropeSouth AmericaAsia.

What is PROGEN's phone number?

Minus sign iconPlus sign icon
You can contact PROGEN's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is PROGEN's stock symbol?

Minus sign iconPlus sign icon
PROGEN is a publicly traded company; the company's stock symbol is PROGEN.ST.

What is PROGEN's official website and social media links?

Minus sign iconPlus sign icon
PROGEN's official website is progen.com and has social profiles on LinkedIn.

What is PROGEN's SIC code NAICS code?

Minus sign iconPlus sign icon
PROGEN's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does PROGEN have currently?

Minus sign iconPlus sign icon
As of October 2025, PROGEN has approximately 49 employees across 6 continents, including EuropeSouth AmericaAsia. Key team members include Chief Executive Officer: K. B.Ceo: M. L.General Manager: S. K.. Explore PROGEN's employee directory with LeadIQ.

What industry does PROGEN belong to?

Minus sign iconPlus sign icon
PROGEN operates in the Biotechnology Research industry.

What technology does PROGEN use?

Minus sign iconPlus sign icon
PROGEN's tech stack includes HotjarOpen GraphAmazon Simple Email ServicePrototypereCAPTCHAGoogle Tag ManagerFedExCivicTheme.

What is PROGEN's email format?

Minus sign iconPlus sign icon
PROGEN's email format typically follows the pattern of First.Last@progen.de. Find more PROGEN email formats with LeadIQ.

When was PROGEN founded?

Minus sign iconPlus sign icon
PROGEN was founded in 1983.
PROGEN

PROGEN

Biotechnology ResearchGermany11-50 Employees

By delivering robust and reliable viral and non-viral gene therapy tools, antibodies, proteins, and kits to scientists worldwide, we empower researchers in academia, biotech, and pharmaceutical industries and commercial manufacturers to advance scientific discovery and develop breakthrough therapies.

Founded in 1983, PROGEN is one of Germany's first biotech companies. We collaborate with gene therapy experts worldwide to design innovative solutions that help scientists overcome research, analytical, and manufacturing challenges.

Beyond supplying products, we partner with our customers to understand their unique needs and provide specialized support throughout their research journey.

PROGEN specializes in: 

- Advanced AAV analytical research tools and standard reagents
- Highly sensitive and widely published AAV ELISA kits
- Premium antibodies optimized for gene therapy applications 
- Lipid nanoparticle (LNP) delivery kits
- Specialized antibodies and proteins for life sciences research

Our commitment extends beyond product manufacturing. We strive to advance life-changing therapies by providing our customers with reliable, consistent, and high-quality tools that meet the exact demands of modern gene therapy development.

Visit www.progen.com to explore our comprehensive catalog of advanced tools!

Making gene therapy better. Together.

Imprint: https://bit.ly/3uEZf2h

Section iconCompany Overview

Headquarters
Maaßstraße 30, Heidelberg, DE
Phone number
Website
progen.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
PROGEN.ST
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1983
Employees
11-50

Section iconFunding & Financials

  • $1M$10M

    PROGEN's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    PROGEN's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.